Westfield, NJ, United States of America

Aaron H Leeman



Average Co-Inventor Count = 8.2

ph-index = 3

Forward Citations = 40(Granted Patents)


Location History:

  • Cranford, NJ (US) (2001 - 2003)
  • Westfield, NJ (US) (2005 - 2011)
  • Portland, ME (US) (2011)

Company Filing History:


Years Active: 2001-2011

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovative Contributions of Aaron H. Leeman

Introduction

Aaron H. Leeman is a notable inventor based in Westfield, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, Leeman has focused on developing compounds that address critical health issues, particularly related to diabetes and metabolic disorders.

Latest Patents

Among his latest patents, Leeman has developed triazole derivatives that serve as selective inhibitors of 11-β hydroxysteroid dehydrogenase-1. These compounds are particularly useful in treating various conditions associated with noninsulin-dependent diabetes (NIDDM), including hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, and Metabolic Syndrome. Additionally, he has worked on sulfonyl compounds that also act as inhibitors of the same enzyme, further contributing to the treatment options available for diabetes and its related symptoms.

Career Highlights

Leeman has had a distinguished career, working with prominent organizations such as Merck & Company, Inc. His work has not only advanced scientific understanding but has also led to practical applications that benefit patients suffering from chronic health conditions.

Collaborations

Throughout his career, Leeman has collaborated with various professionals, including Sherman Tim Waddell and Gina M. Santorelli. These partnerships have played a crucial role in the development and refinement of his innovative compounds.

Conclusion

Aaron H. Leeman's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to improving health outcomes for individuals with diabetes and related disorders. His work continues to inspire advancements in medical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…